|Articles|May 19, 2022

Oracle and NIH Networks Collaborate to Help End HIV

Oracle extends technology first built to fight COVID-19 to accelerate efforts to get a safe and effective HIV vaccine to market.

The HIV Vaccine Trials Network, funded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the NIH, today launched a new HIV awareness campaign and the Red Ribbon Registry with the goal of helping end HIV. Built by Oracle, the cloud-based registry provides a simple sign up process for potential volunteers to be considered for an HIV clinical study.

To learn more or volunteer for an HIV clinical study visit https://www.helpendhiv.org/.

Read more about the collaboration here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.